{
  "$schema": "folio-library-entry/v1",
  "id": "10665-259268",
  "blocks": [
    {
      "id": "library/10665-259268/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 6,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "WHO RECOMMENDATIONS\nON\nMaternal Health\nGUIDELINES APPROVED BY THE \nWHO GUIDELINES REVIEW COMMITTEE\nUPDATED MAY 2017\nWHO RECOMMENDATIONS\nON\nMaternal Health\nGUIDELINES APPROVED BY THE \nWHO GUIDELINES REVIEW COMMITTEE\nUPDATED MAY 2017\nWHO/MCA/17.10\n© World Health Organization 2017\nSome rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-\nShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). \nUnder the terms of this licence, you may copy, redistribute and adapt the work for non-commercial \npurposes, provide",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The front matter of WHO recommendations on maternal health (updated May 2017, WHO/MCA/17.10): title page, copyright and licence page with suggested citation and disclaimers, and a table of contents listing antenatal, childbirth, postnatal and maternal-condition chapters.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Abbreviations",
      "pageStart": 6,
      "pageEnd": 7,
      "target": "../sections/sec-000-abbreviations.md",
      "narrative": null,
      "content": "AIDS\t\nacquired immunodeficiency syndrome\nANC\t\nantenatal care\nART\t\nantiretroviral therapy\nARV\nantiretroviral\nAZT\nzidovudine\nCCT\t\ncontrolled cord traction\nEFZ\nefavirenz\nFTC\nemtricitabine\nGRADE \nGrading of Recommendations, Assessment, Development and Evaluation\nGRC\t\nGuidelines Review Committee\nGDG\t\nGuidelines Development Group\nHIV\t\nhuman immunodeficiency virus\nIM\nintramuscular\nIV\nintravenous\n3TC\nlamuvidine\nNVP\nnevirapine\nNNRTI\t\nnon-nucleotide reverse transcriptase inhibitor\nNRTI\t\nnucleotide reverse transcriptase inhibitor\nPMTCT\t\nprevention of mother-to-child transmission\nPPH\t\npostpartum haemhorra",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A list of abbreviations used in the maternal health recommendations, mostly HIV drugs and terms, along with care and guideline-process acronyms.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Introduction",
      "pageStart": 7,
      "pageEnd": 9,
      "target": "../sections/sec-001-introduction.md",
      "narrative": null,
      "content": "Introduction\nThis publication on WHO recommendations related to maternal health is one of four in a series; \nthe others relate to newborn, child and adolescent health. The objective of this document is to \nmake available WHO recommendations on maternal health in one easy-to-access document \nfor WHO staff, policy-makers, programme managers, and health professionals. The compilation \ncan also help better define gaps to prioritize guideline updates. \nThis document is meant to respond to the questions:\n■What health interventions should be delivered during pregnancy, childbirth and the\npostnatal pe",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces a compilation of WHO maternal health recommendations, one of a four-part series, aimed at WHO personnel, policy-makers, programme managers and health practitioners and to help identify gaps for updating guidelines. Explains how WHO develops guidelines using GRADE ratings of evidence quality and a structured evidence-to-decision framework leading to strong or conditional recommendations, and notes that items are flagged as New or Update relative to 2013.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Promote, prevent and protect maternal and perinatal health",
      "pageStart": 9,
      "pageEnd": 9,
      "target": "../sections/sec-002-promote-prevent-and-protect-maternal-and-perinat.md",
      "narrative": null,
      "content": "maternal and perinatal health\nNEW",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A section heading for promoting, preventing and protecting maternal and perinatal health, marked as new.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Antenatal care",
      "pageStart": 9,
      "pageEnd": 9,
      "target": "../sections/sec-003-1-antenatal-care.md",
      "narrative": null,
      "content": "ANTENATAL CARE FOR A POSITIVE PREGNANCY EXPERIENCE",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A heading introducing antenatal care for a positive pregnancy experience.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Nutritional supplements",
      "pageStart": 9,
      "pageEnd": 10,
      "target": "../sections/sec-004-nutritional-supplements.md",
      "narrative": null,
      "content": "■\n■Counselling about healthy eating and keeping physically active during pregnancy is \nrecommended for pregnant women to stay healthy and to prevent excessive weight gain \nduring pregnancy. (Recommended). Source \n■\n■In undernourished populations, nutrition education on increasing daily energy and protein \nintake is recommended for pregnant women to reduce the risk of low-birth-weight neonates.\n(Context-specific recommendation). Source \n■\n■In undernourished populations, balanced energy and protein dietary supplementation is \nrecommended for pregnant women to reduce the risk of stillbirths and s",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists WHO antenatal recommendations on diet and supplements, including counselling on healthy eating and activity, energy and protein measures in undernourished populations, daily or weekly iron and folic acid, and calcium where intake is low. Vitamin A and zinc are advised only in specific contexts, multiple micronutrients and vitamins B6, C, D and E are not recommended, and lowering caffeine intake is advised for heavy consumers.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Maternal and fetal assessment",
      "pageStart": 10,
      "pageEnd": 12,
      "target": "../sections/sec-005-maternal-and-fetal-assessment.md",
      "narrative": null,
      "content": "Anaemia\t\n■\n■Full blood count testing is the recommended method for diagnosing anaemia in pregnancy. \nIn settings where full blood count testing is not available, on-site haemoglobin testing with \na haemoglobinometer is recommended over the use of the haemoglobin colour scale as the \nmethod for diagnosing anaemia in pregnancy. (Context-specific recommendation). Source \nAsymptomatic bacteriuria (ASB)\t\n■\n■Midstream urine culture is the recommended method for diagnosing asymptomatic \nbacteriuria (ASB) in pregnancy. In settings where urine culture is not available, on-site \nmidstream urine Gram-sta",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out recommended antenatal assessments, including preferred tests for anaemia and asymptomatic bacteriuria, classifying hyperglycaemia found in pregnancy, HIV testing and counselling, TB screening in high-prevalence settings, and asking about intimate partner violence, tobacco and other substance use. It also states that routine cardiotocography, Doppler scans and replacing palpation with fundal-height measurement are not recommended, kick-chart counting only in research, and one ultrasound before 24 weeks is advised.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Preventive measures",
      "pageStart": 12,
      "pageEnd": 13,
      "target": "../sections/sec-006-preventive-measures.md",
      "narrative": null,
      "content": "Antibiotics for asymptomatic bacteriuria (ASB)\t\n■\n■A seven-day antibiotic regimen is recommended for all pregnant women with asymptomatic \nbacteriuria (ASB) to prevent persistent bacteriuria, preterm birth and low birth weight. \n(Recommended). Source \nAntibiotic prophylaxis to prevent recurrent urinary tract infections (RUTI)\t\n■\n■Antibiotic prophylaxis is only recommended to prevent recurrent urinary tract infections \nin pregnant women in the context of rigorous research. (Context-specific recommendation/\nresearch). Source \nAntenatal anti-D immunoglobulin prophylaxis\t\n■\n■Antenatal prophylaxis",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists preventive measures in pregnancy, such as a seven-day antibiotic course for asymptomatic bacteriuria, deworming in endemic areas after the first trimester, tetanus toxoid and influenza vaccination, bed nets and sulfadoxine-pyrimethamine preventive treatment against malaria. Anti-D prophylaxis and antibiotics for recurrent urinary infections are reserved for research, and the section also covers primaquine use to prevent vivax or ovale malaria relapse according to G6PD status and oral PrEP for pregnant women at substantial HIV risk.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Interventions for common physiological symptoms",
      "pageStart": 13,
      "pageEnd": 14,
      "target": "../sections/sec-007-interventions-for-common-physiological-symptoms.md",
      "narrative": null,
      "content": "Nausea and vomiting\t\n■\n■Ginger, chamomile, vitamin B6 and/or acupuncture are recommended for the relief of nausea \nin early pregnancy, based on a woman’s preferences and available options. (Recommended).\nSource \nHeartburn\t\n■\n■Advice on diet and lifestyle is recommended to prevent and relieve heartburn in pregnancy. \nAntacid preparations can be offered to women with troublesome symptoms that are not \nrelieved by lifestyle modification. (Recommended). Source \nLeg cramps\t\n■\n■Magnesium, calcium or non-pharmacological treatment options can be used for the \nrelief of leg cramps in pregnancy, based o",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives recommended options for common pregnancy discomforts, including ginger, chamomile, vitamin B6 or acupuncture for nausea and diet and lifestyle advice or antacids for heartburn. It also covers leg cramps, low back and pelvic pain, constipation, and varicose veins and oedema, with choices guided by the woman's preferences and what is available.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Health systems interventions",
      "pageStart": 14,
      "pageEnd": 15,
      "target": "../sections/sec-008-health-systems-interventions.md",
      "narrative": null,
      "content": "antenatal care\nWoman-held case notes\t\n■\n■It is recommended that each pregnant woman carries her own case notes during pregnancy \nto improve continuity, quality of care and her pregnancy experience. (Recommended). \nSource\nMidwife-led continuity of care\t\n■\n■Midwife-led continuity-of-care models, in which a known midwife or small group of known \nmidwives supports a woman throughout the antenatal, intrapartum and postnatal contin-\nuum, are recommended for pregnant women in settings with well-functioning midwifery \nprogrammes. (Context-specific recommendation). Source \nGroup antenatal care\t\n■\n■Grou",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists health-system recommendations for antenatal care, including women carrying their own case notes, midwife-led continuity of care, group antenatal care in research settings, women's group participatory learning cycles, and community mobilization with home visits. It also covers task shifting of health promotion and supplement distribution to various cadres, measures to recruit and keep health workers in rural areas, and a schedule of at least eight antenatal contacts.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Prevention of pre-eclampsia and eclampsia",
      "pageStart": 15,
      "pageEnd": 16,
      "target": "../sections/sec-009-2-prevention-of-pre-eclampsia-and-eclampsia.md",
      "narrative": null,
      "content": "PREVENTION OF PRE-ECLAMPSIA AND ECLAMPSIA\n■\n■In populations with low dietary calcium intake, daily calcium supplementation (1.5–2.0 g \noral elemental calcium) is recommended for pregnant women to reduce the risk of pre-\neclampsia. (Context-specific recommendation). Source \n■\n■Low-dose acetylsalicylic acid (aspirin, 75 mg) is recommended for the prevention of pre-\neclampsia in women at high risk of developing the condition. (Strong recommendation, \nmoderate quality evidence). Source\n■\n■\tLow-dose acetylsalicylic acid (aspirin, 75 mg) for the prevention of pre-eclampsia and \nits related complicat",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out recommendations on preventing pre-eclampsia and eclampsia, including calcium supplements where intake is low, low-dose aspirin for high-risk women started before 20 weeks, and treating severe hypertension. Home rest, strict bed rest, salt restriction and diuretics such as thiazides are not recommended for this purpose.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Interventions to improve preterm birth outcomes",
      "pageStart": 16,
      "pageEnd": 18,
      "target": "../sections/sec-010-3-interventions-to-improve-preterm-birth-outcome.md",
      "narrative": null,
      "content": "INTERVENTIONS TO IMPROVE PRETERM BIRTH OUTCOMES\nNEW\nAntenatal corticosteroids to improve newborn outcomes\t\n■\n■Antenatal corticosteroid therapy is recommended for women at risk of preterm birth from \n24 weeks to 34 weeks of gestation when the following conditions are met:\n—\n— gestational age assessment can be accurately undertaken;\n—\n— preterm birth is considered imminent;\n—\n— there is no clinical evidence of maternal infection;\n—\n— adequate childbirth care is available (including the capacity to recognize and safely \nmanage preterm labour and birth);\n—\n— the preterm newborn can receive adequat",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Presents new recommendations to improve outcomes of preterm birth, centred on antenatal corticosteroids for women at risk between 24 and 34 weeks when conditions such as accurate dating, imminent birth, no maternal infection and adequate maternal and newborn care are met. It specifies use in multiple pregnancies, preterm prelabour rupture of membranes, hypertensive disorders, fetal growth restriction and diabetes, names dexamethasone or betamethasone as the drugs of choice, allows one repeat course, and excludes chorioamnionitis and planned late-preterm caesarean section. It also advises against tocolytics, routine antibiotics with intact membranes and routine caesarean delivery, while recommending magnesium sulfate before 32 weeks and antibiotics such as erythromycin after membrane rupture, but not co-amoxiclav.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Prevention of maternal peripartum infections",
      "pageStart": 18,
      "pageEnd": 19,
      "target": "../sections/sec-011-4-prevention-of-maternal-peripartum-infections.md",
      "narrative": null,
      "content": "PREVENTION OF MATERNAL PERIPARTUM INFECTIONS \nNEW\n■\n■Routine perineal/pubic shaving prior to giving vaginal birth is not recommended. (Conditional \nrecommendation based on very low-quality evidence). Source\n■\n■Digital vaginal examination at intervals of four hours is recommended for routine assessment \nof active first stage of labour in low-risk women. (Strong recommendation based on very low-\nquality evidence). Source\n■\n■Routine vaginal cleansing with chlorhexidine during labour for the purpose of preventing \ninfectious morbidities is not recommended. (Strong recommendation based on moderate-",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists new recommendations on preventing maternal infections around childbirth, advising against routine shaving, chlorhexidine vaginal cleansing and routine antibiotics in situations such as preterm labour with intact membranes, term membrane rupture, meconium, operative vaginal birth, episiotomy and uncomplicated birth. Antibiotics are recommended for GBS colonization, preterm membrane rupture, manual placenta removal, severe perineal tears and caesarean section, given before incision as a single dose of first-generation cephalosporin or penicillin, with povidone-iodine vaginal cleansing beforehand.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Labour and child birth",
      "pageStart": 19,
      "pageEnd": 19,
      "target": "../sections/sec-012-5-labour-and-child-birth.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-013",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Induction of labour",
      "pageStart": 19,
      "pageEnd": 20,
      "target": "../sections/sec-013-induction-of-labour.md",
      "narrative": null,
      "content": "When induction of labour may be appropriate\n■\n■Induction of labour is recommended for women who are known with certainty to have \nreached 41 weeks (>40 weeks + 7 days) of gestation. (Weak recommendation, low quality of \nevidence). Source\n■\n■Induction of labour is not recommended in women with an uncomplicated pregnancy at \ngestational age less than 41 weeks. (Weak recommendation, low quality of evidence). Source\n■\n■If gestational diabetes is the only abnormality, induction of labour before 41 weeks of \ngestation is not recommended. (Weak recommendation, very low quality evidence). Source\n■\n■In",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out recommendations on when to induce labour, such as at 41 completed weeks or after prelabour membrane rupture at term, but not for uncomplicated pregnancies before 41 weeks, gestational diabetes alone or suspected macrosomia. Recommended methods include oral or low-dose vaginal misoprostol (not after previous caesarean), vaginal prostaglandins, balloon catheter with or without oxytocin and membrane sweeping, with betamimetics for uterine hyperstimulation and outpatient induction not recommended.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-014",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Delay in the first stage of labour",
      "pageStart": 20,
      "pageEnd": 21,
      "target": "../sections/sec-014-delay-in-the-first-stage-of-labour.md",
      "narrative": null,
      "content": "NEW\n■\n■Active phase partograph with a four-hour action line is recommended for monitoring the \nprogress of labour. (Quality of evidence low, Strength of recommendation strong). Source\n■\n■Digital vaginal examination at intervals of four hours is recommended for routine assessment \nand identification of delay in active labour. (Quality of evidence very low, Strength of \nrecommendation weak). Source\nPrevention of delay in the first stage of labour\t\nNEW\n■\n■A package of care for active management of labour for prevention of delay in labour is not \nrecommended. (Quality of evidence low, Strength of",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Presents new recommendations on monitoring and managing delay in the first stage of labour, including a partograph with a four-hour action line and four-hourly vaginal examinations, with active management packages, early amniotomy, routine oxytocin, antispasmodics, intravenous fluids and enemas not recommended for prevention. Oral intake, mobility, upright positions and continuous companionship are encouraged, and for confirmed delay oxytocin alone or with amniotomy is recommended, but not oral misoprostol, high-dose regimens or internal tocodynamometry.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-015",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Prevention of postpartum haemorrhage",
      "pageStart": 21,
      "pageEnd": 22,
      "target": "../sections/sec-015-6-prevention-of-postpartum-haemorrhage.md",
      "narrative": null,
      "content": "PREVENTION OF POSTPARTUM HAEMORRHAGE (PPH)\n■\n■The use of uterotonics for the prevention of PPH during the third stage of labour is \nrecommended for all births. (Strong recommendation, moderate quality evidence). Source\n■\n■Oxytocin (10 IU, IV/IM) is the recommended uterotonic drug for the prevention of PPH. \n(Strong recommendation, moderate quality evidence). Source\n■\n■In settings where oxytocin is unavailable, the use of other injectable uterotonics (if \nappropriate ergometrine/methylergometrine or the fixed drug combination of oxytocin \n16\nWHO RECOMMENDATIONS ON MATERNAL HEALTH\nand ergometrin",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out recommendations to prevent postpartum haemorrhage, chiefly a uterotonic for every birth with oxytocin preferred, alternatives such as ergometrine or oral misoprostol where oxytocin is unavailable, and misoprostol given by community and lay health workers where no skilled attendant is present. It also covers controlled cord traction depending on attendant availability, late rather than early cord clamping, no sustained uterine massage after oxytocin, routine uterine tone checks, and oxytocin and cord traction in caesarean section.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-016",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Postnatal care",
      "pageStart": 22,
      "pageEnd": 25,
      "target": "../sections/sec-016-7-postnatal-care.md",
      "narrative": null,
      "content": "POSTNATAL CARE\nTiming of discharge from the health facility\n■\n■After an uncomplicated vaginal birth in a health facility, healthy mothers and newborns \nshould receive care in the facility for at least 24 hours after birth. (Weak recommendation, \nlow quality evidence). Source\nTiming and number of postnatal contacts\n■\n■If birth is in a health facility, mothers and newborns should receive postnatal care in the \nfacility for at least 24 hours after birth. Source\n■\n■If birth is at home, the first postnatal contact should be as early as possible within 24 hours \nof birth. Source\n■\n■At least three ad",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out WHO recommendations on postnatal care, including a stay of at least 24 hours in the facility after an uncomplicated birth and a schedule of at least four postnatal contacts, with home visits in the first week. It describes how the mother should be assessed in the first day and at later contacts, covering bleeding, vital signs, recovery, breastfeeding, mood, depression and signs of domestic abuse. It also lists counselling topics, warning signs to report, nutrition advice with iron and folic acid supplementation, and psychosocial support, family planning, hygiene and exercise.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-017",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": ". Health promotion for maternal and newborn health",
      "pageStart": 25,
      "pageEnd": 28,
      "target": "../sections/sec-017-8-health-promotion-for-maternal-and-newborn-heal.md",
      "narrative": null,
      "content": "HEALTH PROMOTION FOR MATERNAL AND NEWBORN HEALTH \nNEW\nBirth Preparedness and Complication Readiness\t\n■\n■Birth Preparedness and Complication Readiness interventions are recommended to increase \nthe use of skilled care at birth and to increase the timely use of facility care for obstetric and \nnewborn complications. (Strong recommendation, very low quality of evidence). Additional \nresearch is required. Source\nMale involvement interventions for MNH\t\n■\n■Interventions to promote the involvement of men during pregnancy, childbirth and \nafter birth are recommended to facilitate and support improved",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists WHO recommendations on health promotion for maternal and newborn health, such as birth preparedness, involving men, maternity waiting homes, community transport schemes, partnership with traditional birth attendants and a companion of choice during labour. It also recommends community engagement through women's groups and community participation in quality improvement and programme planning, and calls for more research on community roles in maternal death surveillance and on rights awareness.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-018",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Management of maternal conditions",
      "pageStart": 28,
      "pageEnd": 28,
      "target": "../sections/sec-018-management-of-maternal-conditions.md",
      "narrative": null,
      "content": "maternal conditions",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A section heading for the management of maternal conditions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-019",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Postpartum haemorrhage",
      "pageStart": 28,
      "pageEnd": 29,
      "target": "../sections/sec-019-9-postpartum-haemorrhage.md",
      "narrative": null,
      "content": "TREATMENT OF POSTPARTUM HAEMORRHAGE3\n■\n■Intravenous oxytocin alone is the recommended uterotonic drug for the treatment of PPH.\n(Strong recommendation, moderate quality evidence). Source\n■\n■If intravenous oxytocin is unavailable, or if the bleeding does not respond to oxytocin, the \nuse of intravenous ergometrine, oxytocin-ergometrine fixed dose, or a prostaglandin drug \n(including sublingual misoprostol, 800 µg) is recommended. (Strong recommendation, low \nquality evidence). Source\n■\n■The use of isotonic crystalloids is recommended in preference to the use of colloids for the \ninitial intrave",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out WHO recommendations for treating postpartum haemorrhage, starting with intravenous oxytocin and alternative uterotonics, crystalloid fluids, tranexamic acid and uterine massage. It then covers escalating and temporizing measures such as balloon tamponade, embolization, surgery, bimanual or aortic compression and anti-shock garments, along with the management of retained placenta. The block ends with the first recommendations on pre-eclampsia and eclampsia, favouring magnesium sulfate over other anticonvulsants.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-020",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Pre-eclampsia and eclampsia",
      "pageStart": 29,
      "pageEnd": 30,
      "target": "../sections/sec-020-10-pre-eclampsia-and-eclampsia.md",
      "narrative": null,
      "content": "(Weak recommendation, very low quality evidence). Source\n■\n■Induction of labour is recommended for women with severe preeclampsia at a gestational \nage when the fetus is not viable or unlikely to achieve viability within one or two weeks.\n(Strong recommendation, very low quality evidence). Source\t\n■\n■In women with severe pre-eclampsia, a viable fetus and before 34 weeks of gestation, a \npolicy of expectant management is recommended, provided that uncontrolled maternal \nhypertension, increasing maternal organ dysfunction or fetal distress are absent and can be \nmonitored. (Weak recommendation,",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Continues WHO recommendations on severe pre-eclampsia, covering when to induce labour, when expectant management is acceptable by gestational age, and early delivery at term. It also recommends continuing or starting antihypertensive treatment after birth and advises against corticosteroids specifically for HELLP syndrome.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-021",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Peripartum infections",
      "pageStart": 30,
      "pageEnd": 30,
      "target": "../sections/sec-021-11-peripartum-infections.md",
      "narrative": null,
      "content": "NEW\n■\n■A simple regimen such as ampicillin and once-daily gentamicin is recommended as first-\nline antibiotics for the treatment of chorioamnionitis. (Conditional recommendation based \non very low-quality evidence). Source\n■\n■A combination of clindamycin and gentamicin is recommended as first-line antibiotics for \nthe treatment of postpartum endometritis. (Conditional recommendation based on very low-\nquality evidence). Source",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Recommends first-line antibiotic regimens for chorioamnionitis (ampicillin with once-daily gentamicin) and for postpartum endometritis (clindamycin with gentamicin).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-022",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "HIV infection",
      "pageStart": 30,
      "pageEnd": 33,
      "target": "../sections/sec-022-12-hiv-infection.md",
      "narrative": null,
      "content": "HIV diagnosis\n■\n■Couples and partners in antenatal care settings should be offered voluntary HIV testing \nand counselling with support for mutual disclosure. (Strong recommendation, low quality \nevidence). Source\nGeneralized epidemics\n■\n■Provider-initiated testing and counselling is recommended for women as a routine \ncomponent of the package of care in all antenatal, childbirth, postpartum and paediatric \ncare settings. (No strength, no quality of evidence). Source quoted also in Source\n■\n■Re-testing is recommended in the third trimester, or during labour or shortly after delivery, \nbecause o",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out WHO recommendations on HIV in pregnant and breastfeeding women, starting with couple testing and provider-initiated testing in generalized and low-level epidemics. It covers when to start antiretroviral therapy, practices to reduce transmission during labour and delivery, non-stigmatizing care, and follow-up of mothers and HIV-exposed infants. It also names the preferred first-line ART regimen, infant prophylaxis by feeding type, and advises against vitamin A supplementation to reduce mother-to-child transmission.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-023",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Malaria",
      "pageStart": 33,
      "pageEnd": 33,
      "target": "../sections/sec-023-13-malaria.md",
      "narrative": null,
      "content": "NEW\nTreating uncomplicated P. falciparum malaria in special risk groups\nFirst trimester of pregnancy\n■\n■Treat pregnant women with uncomplicated P. falciparum malaria during the first trimester \nwith 7 days of quinine + clindamycin. (Strong recommendation). Source\nPregnant and breastfeeding women\n■\n■In women who are pregnant or breastfeeding, consider weekly chemoprophylaxis with \nchloroquine until delivery and breastfeeding are completed, then, on the basis of G6PD \nstatus, treat with primaquine to prevent future relapse. (Conditional recommendation, \nmoderate-quality evidence). Source",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives WHO recommendations for uncomplicated falciparum malaria in the first trimester (seven days of quinine plus clindamycin) and for chloroquine chemoprophylaxis in pregnant or breastfeeding women, followed by primaquine depending on G6PD status.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-259268/blocks/prose-sec-024",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Tuberculosis",
      "pageStart": 33,
      "pageEnd": 36,
      "target": "../sections/sec-024-14-tuberculosis.md",
      "narrative": null,
      "content": "NEW\nNutritional Care and support for patients with tuberculosis\n■\n■Pregnant women with active TB and moderate undernutrition, or with inadequate weight \ngain, should be provided with locally available nutrient rich or fortified supplementary foods, \nas necessary to achieve an average weekly minimum weight gain of approximately 300 g in \nthe second and third trimesters. (Strong recommendation, very low quality of evidence)\n■\n■Patients with active multidrug-resistant TB and moderate undernutrition should be provided \nwith locally available nutrient-rich or fortified supplementary foods, as neces",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out WHO recommendations on nutritional care for pregnant and lactating women with active tuberculosis, including fortified or supplementary foods to reach a target weekly weight gain. It also recommends multiple micronutrient supplements with iron and folic acid, and calcium to prevent pre-eclampsia where intake is low.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
